X4 PHARMACEUTICALS, INC Deferred Tax Assets, Operating Loss Carryforwards
X4 PHARMACEUTICALS, INC (XFOR) had Deferred Tax Assets, Operating Loss Carryforwards of $129.94 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-17
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $129.94M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $115.33M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $122.94M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $107.30M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $129.94M 10-K · filed 2026-03-17 | |
| 2024-12-31 | $115.33M 10-K · filed 2026-03-17 | |
| 2023-12-31 | $122.94M 10-K · filed 2025-03-26 | |
| 2022-12-31 | $107.30M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $101.86M 10-K · filed 2023-03-21 | |
| 2020-12-31 | $83.67M 10-K · filed 2022-03-17 | |
| 2019-12-31 | $65.49M 10-K · filed 2021-03-19 | |
| 2018-12-31 | $15.48M 10-K · filed 2020-03-12 | $26.52M 10-K · filed 2019-03-11 |
| 2017-12-31 | $20.22M 10-K · filed 2019-03-11 | |
| 2016-12-31 | $13.13M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |